查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲轉染試劑和設備市場預測至 2030 年 - 區域分析 - 按產品、方法、應用和最終用戶
市場調查報告書
商品編碼
1562262

歐洲轉染試劑和設備市場預測至 2030 年 - 區域分析 - 按產品、方法、應用和最終用戶

Europe Transfection Reagents and Equipment Market Forecast to 2030 - Regional Analysis - by Product, Method, Application, and End User
出版日期: | 出版商: The Insight Partners | 英文 112 Pages | 訂單完成後即時交付

價格

2022年歐洲轉染試劑和設備市場估值為30,604萬美元，預計2030年將達55,546萬美元；預計 2022 年至 2030 年複合年成長率為 7.7%。

公司的策略性舉措推動歐洲轉染試劑和設備市場

轉染是開發病毒載體整個過程中的複雜步驟，病毒載體包括腺病毒、腺相關病毒和慢病毒。隨著製造流程規模的擴大，瞬時轉染也必須加強。製程設備供應商、藥物開發人員和原料供應商正致力於合作開發具有成本效益、實用且可平台化的解決方案，以實現病毒載體製造流程的快速開發和規模化。在小規模上，透過計劃的材料體積以及轉移和混合時間，用多個質粒轉染細胞變得可行。由於大多數公司僅擁有實驗室級的轉染經驗，因此擴大規模需要工業化轉染步驟的經驗。然而，將製程擴大到更大水平所需的細胞培養基和轉染試劑的體積可能不切實際，這強調了最佳化的必要性。儘管如此，近年來隨著病毒載體需求的激增，擴大生產規模已變得普遍。由於大規模轉染製程面臨許多挑戰，提高產量的最佳方法是減少製程而不是擴大製程規模。這種自上而下的方法可以清楚地識別影響工業水平過程的條件，例如轉染複合物溶液的體積。這種方法也有助於流程最佳化和決策。這種提高小規模轉染製程的方法的開發為歐洲轉染試劑和設備市場的成長提供了機會。

歐洲轉染試劑與設備市場概況

歐洲地區分為英國、德國、法國、西班牙、義大利和歐洲其他地區。到 2022 年，英國將佔據最大的市場佔有率。英國是世界上先進療法的研究、開發、製造、臨床採用和報銷的最佳生態系統之一。目前，英國正在進行超過 85 項臨床試驗，70 家 CGT 公司正在努力開發潛在的治療方法。 Catapult 是一家頂級公司，一直為英國的 CGT 生態系統做出了重大貢獻；它是該國參與開發試劑和設備製造流程的前五家公司之一。該公司專注於開發更智慧的自動化 CGT 製造流程，能夠以最少的干涉自動適應不斷變化的環境和流程要求。因此，英國公司在提高生產力和降低最終產品成本方面所做的努力是推動英國細胞和基因療法市場成長的主要因素。此外，由於持續且有針對性的研究投資，英國在歐洲細胞和基因治療市場佔據強勢地位，進一步有利於市場。

此外，法國還有賽諾菲、益普森、皮爾法伯、HRA Pharma、TxCell（Sangamo Therapeutics, Inc.）等生物製藥和製藥巨頭。這些公司參與疫苗和抗體等的開發，其產品需要冷凍乾燥，這增加了對轉染試劑和設備的需求。

歐洲轉染試劑和設備市場收入及2030年預測（百萬美元）

歐洲轉染試劑和設備市場細分

歐洲轉染試劑和設備市場根據產品、方法、應用、最終用戶和國家進行細分。

根據產品，歐洲轉染試劑和設備市場分為試劑和儀器。 2022 年，試劑細分市場將佔更大佔有率。

從方法來看，歐洲轉染試劑和設備市場分為病毒法、非病毒法和混合法。 2022 年，非病毒方法部分佔最大佔有率。非病毒部分分為物理/機械方法和化學方法。此外，物理/機械方法細分為電穿孔、顯微注射、生物彈體方法、雷射方法、磁轉染和聲穿孔。此外，化學方法部分又分為基於脂質體/高脂質和基於非脂質體/高脂質。

按應用分類，歐洲轉染試劑和設備市場分為生物醫學研究、蛋白質生產和治療遞送。 2022 年，生物醫學研究領域佔最大佔有率。

根據最終用戶，歐洲轉染試劑和設備市場分為學術和研究機構以及製藥和生物技術公司。 2022 年，學術和研究機構領域佔據了更大的佔有率。

依國家分類，歐洲轉染試劑和設備市場分為德國、法國、英國、義大利、西班牙和歐洲其他地區。 2022年，英國將主導歐洲轉染試劑和設備市場。

Fisher Scientific Inc、Promega Corp、F. Hoffmann-La Roche Ltd、Bio-Rad Laboratories Inc、Mirus Bio LLC、QIAGEN NV、Merck KGaA、Lonza Group AG、MaxCyte Inc 和 Polyplus-Transfection SA 是營運中的一些領先公司在歐洲轉染試劑和設備市場。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：歐洲轉染試劑與設備市場 - 主要市場動態

  • 歐洲轉染試劑和設備市場 - 主要市場動態
  • 市場促進因素
    • 細胞和基因療法越來越受歡迎
    • 癌症帶來的經濟負擔日益沉重
  • 市場限制
    • 儀器及耗材成本高
  • 市場機會
    • 將小規模流程升級為大規模流程
  • 未來趨勢
    • 公司的策略舉措
  • 促進因素和限制的影響：

第 5 章：轉染試劑與設備市場 - 歐洲市場分析

  • 2022-2030年歐洲轉染試劑與設備市場收入
  • 歐洲轉染試劑及設備市場預測分析

第 6 章：歐洲轉染試劑與設備市場分析 - 按產品

  • 試劑
  • 裝置

第 7 章：歐洲轉染試劑與設備市場分析 - 依方式

  • 病毒性的
  • 非病毒性
  • 混合

第 8 章：歐洲轉染試劑和設備市場分析 - 按應用

  • 生物醫學研究
  • 蛋白質生產
  • 治療實施

第 9 章：歐洲轉染試劑和設備市場分析 - 按最終用戶

  • 學術及研究機構
  • 製藥和生物技術公司

第 10 章：歐洲轉染試劑與設備市場 - 國家分析

  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區

第 11 章：轉染試劑與設備市場 - 產業格局

  • 概述
  • 2020-2023 年轉染試劑和設備市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第 12 章：公司簡介

  • Thermo Fisher Scientific Inc
  • Promega Corp
  • F. Hoffmann-La Roche Ltd
  • Bio-Rad Laboratories Inc
  • Mirus Bio LLC
  • QIAGEN NV
  • Merck KGaA
  • Lonza Group AG
  • MaxCyte Inc
  • Polyplus-Transfection SA

第 13 章：附錄

Product Code: BMIRE00030436

The Europe transfection reagents and equipment market was valued at US$ 306.04 million in 2022 and is expected to reach US$ 555.46 million by 2030; it is estimated to register at a CAGR of 7.7% from 2022 to 2030.

Strategic Initiatives by Companies Drive Europe Transfection Reagents and Equipment Market

Transfection is the complex step in the overall process of developing a viral vector, which includes adenovirus, adeno-associated virus, and lentivirus. As the manufacturing processes are scaled up, transient transfection must also be ramped up. Process equipment vendors, drug developers, and raw material suppliers are focusing on collaborations to develop cost-effective, practical, and platformizable solutions for the rapid development and scaling up of viral vector manufacturing processes. On small scales, with planned material volumes and transfer & mixing times, transfecting cells with multiple plasmids becomes feasible. Scaling up requires experience in industrializing the transfection step since most companies only have transfection experience at the lab level. However, the volume of cell-culture media and transfection reagents required for scaling up the process to a larger level can be impractical, which emphasizes the need for optimization. Nonetheless, broadening the scale of production has become common in recent years with the surging demand for viral vectors. With numerous challenges associated with large-scale transfection processes, the best approach to increase production is by reducing the process rather than scaling up the process. This top-down approach allows clear identification of the conditions that will impact the process at the industrial level such as the volume of transfection complex solution. This approach also facilitates process optimization and decision-making. The development of such approaches to ramp up the small-scale transfection processes acts as an opportunity for the growth of the Europe transfection reagents and equipment market.

Europe Transfection Reagents and Equipment Market Overview

Europe region segmented into UK, Germany, France, Spain, Italy, and Rest of Europe. United Kingdom holds the largest market share in the year 2022. The growth of the pharmaceutical industry is determined by the high-quality research and development ongoing in the country, and extensive and flourishing healthcare knowledge base. The UK is one of the world's best ecosystems for research, development, manufacturing, clinical adoption, and reimbursement of advanced therapeutics. Currently, over 85 clinical trials are ongoing in the UK, and 70 CGT companies are striving to develop potentially curative therapies. Catapult is a top company that has been contributing significantly to the CGT ecosystem in the UK; it stands as one of the top five companies involved in developing manufacturing processes of reagents and devices in the country. The company is focused on developing smarter automated CGT manufacturing processes that can automatically adapt to changing environments and process requirements with minimal intervention. Therefore, efforts made by UK-based companies to enhance productivity and reduce final product costs are the major factors driving the growth of the cell and gene therapy market in the UK. Moreover, the UK holds a strong position in the cell and gene therapy market in Europe owing to sustained and targeted investment in research, which further benefits the market.

Moreover, France has the presence of biopharmaceutical and pharmaceutical giants such as Sanofi S.A., Ipsen, Pierre Fabre, HRA Pharma, and TxCell (Sangamo Therapeutics, Inc.). These companies are involved in the development of vaccines and antibodies, among others, which require freeze-drying for their products, which contributes to the demand for transfection reagents and equipment.

Europe Transfection Reagents and Equipment Market Revenue and Forecast to 2030 (US$ Million)

Europe Transfection Reagents and Equipment Market Segmentation

The Europe transfection reagents and equipment market is segmented based on product, method, application, end user, and country.

Based on product, the Europe transfection reagents and equipment market is bifurcated into reagents and instruments. The reagents segment held a larger share in 2022.

In terms of method, the Europe transfection reagents and equipment market is segmented into viral methods, non-viral methods, and hybrid methods. The non-viral methods segment held the largest share in 2022. The viral segment is subcategorized into retrovirus, adenovirus, adeno associated virus, and herpes virus. The non-viral segment is bifurcated into physical/mechanical method and chemical method. Further, the physical/mechanical method segment is subcategorized into electroporation, microinjection, biolistic method, laser method, magnetofection, and sonoporation. Also, the chemical method segment is subcategorized into liposomal based/high lipid and non-liposomal/high lipid based.

By application, the Europe transfection reagents and equipment market is segmented into biomedical research, protein production, and therapeutic delivery. The biomedical research segment held the largest share in 2022.

Based on end user, the Europe transfection reagents and equipment market is bifurcated into academics & research institutes and pharmaceutical & biotechnology companies. The academics & research institutes segment held a larger share in 2022.

Based on country, the Europe transfection reagents and equipment market is categorized into Germany, France, the UK, Italy, Spain, and the Rest of Europe. The UK dominated the Europe transfection reagents and equipment market in 2022.

Fisher Scientific Inc, Promega Corp, F. Hoffmann-La Roche Ltd, Bio-Rad Laboratories Inc, Mirus Bio LLC, QIAGEN NV, Merck KGaA, Lonza Group AG, MaxCyte Inc, and Polyplus-Transfection SA are some of the leading companies operating in the Europe transfection reagents and equipment market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transfection Reagents and Equipment Market - Key Market Dynamics

  • 4.1 Europe Transfection Reagents and Equipment Market - Key Market Dynamics
  • 4.2 Market Drivers
    • 4.2.1 Increasing Popularity of Cell and Gene Therapy
    • 4.2.2 Growing Economic Burden of Cancer
  • 4.3 Market Restraints
    • 4.3.1 High Cost of Instruments and Consumables
  • 4.4 Market Opportunities
    • 4.4.1 Ramping Up Small-Scale Processes to Large-Scale Processes
  • 4.5 Future Trends
    • 4.5.1 Strategic Initiatives by Companies
  • 4.6 Impact of Drivers and Restraints:

5. Transfection Reagents and Equipment Market - Europe Market Analysis

  • 5.1 Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • 5.2 Europe Transfection Reagents and Equipment Market Forecast Analysis

6. Europe Transfection Reagents and Equipment Market Analysis - by Product

  • 6.1 Reagents
    • 6.1.1 Overview
    • 6.1.2 Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.2 Equipment
    • 6.2.1 Overview
    • 6.2.2 Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transfection Reagents and Equipment Market Analysis - by Modality

  • 7.1 Viral
    • 7.1.1 Overview
    • 7.1.2 Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.1 Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.2 Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.3 Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.1.2.4 Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Non-Viral
    • 7.2.1 Overview
    • 7.2.2 Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.1 Physical/Mechanical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.1 Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.2 Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.3 Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.4 Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.5 Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.1.6 Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.2.2.2 Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.1 Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
        • 7.2.2.2.2 Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Hybrid
    • 7.3.1 Overview
    • 7.3.2 Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transfection Reagents and Equipment Market Analysis - by Application

  • 8.1 Biomedical Research
    • 8.1.1 Overview
    • 8.1.2 Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Protein Production
    • 8.2.1 Overview
    • 8.2.2 Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.3 Therapeutic Delivery
    • 8.3.1 Overview
    • 8.3.2 Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transfection Reagents and Equipment Market Analysis - by End Users

  • 9.1 Academic and Research Institutes
    • 9.1.1 Overview
    • 9.1.2 Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Pharmaceutical and Biotechnological Companies
    • 9.2.1 Overview
    • 9.2.2 Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)

10. Europe Transfection Reagents and Equipment Market -Country Analysis

  • 10.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.1 Europe: Transfection Reagents and Equipment Market - Revenue and Forecast Analysis - by Country
    • 10.1.2 United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.2.2.2.1 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.2.2.2.2 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.2.3 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.2.4 United Kingdom: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.3 Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.3.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.3.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.3.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.3.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.3.2.2.1 Germany: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.3.2.2.2 Germany: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.3.3 Germany: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.3.4 Germany: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.4 France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.4.1 France: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.4.2 France: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.4.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.4.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.4.2.2.1 France: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.4.2.2.2 France: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.4.3 France: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.4.4 France: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.5 Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.5.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.5.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.5.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.5.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.5.2.2.1 Italy: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.5.2.2.2 Italy: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.5.3 Italy: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.5.4 Italy: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.6 Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.6.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.6.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.6.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.6.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.6.2.2.1 Spain: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.6.2.2.2 Spain: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.6.3 Spain: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.6.4 Spain: Transfection Reagents and Equipment Market Breakdown, by End Users
    • 10.1.7 Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
      • 10.1.7.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Product
      • 10.1.7.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Modality
        • 10.1.7.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Viral
        • 10.1.7.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Non-Viral
        • 10.1.7.2.2.1 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Physical/mechanical Method
        • 10.1.7.2.2.2 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Chemical Method
      • 10.1.7.3 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by Application
      • 10.1.7.4 Rest of Europe: Transfection Reagents and Equipment Market Breakdown, by End Users

11. Transfection Reagents and Equipment Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Thermo Fisher Scientific Inc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Promega Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 F. Hoffmann-La Roche Ltd
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Bio-Rad Laboratories Inc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Mirus Bio LLC
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 QIAGEN NV
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Merck KGaA
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Lonza Group AG
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 MaxCyte Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Polyplus-Transfection SA
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us

List Of Tables

  • Table 1. Europe Transfection Reagents and Equipment Market Segmentation
  • Table 2. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Product
  • Table 4. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Modality
  • Table 5. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Viral
  • Table 6. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Non-Viral
  • Table 7. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Physical/mechanical Method
  • Table 8. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Chemical Method
  • Table 9. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by Application
  • Table 10. Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million) - by End Users
  • Table 11. Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 12. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 13. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 14. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 15. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 16. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 17. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 18. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 19. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 20. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 21. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 22. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 23. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 24. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 25. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 26. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 27. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 28. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 29. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 30. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 31. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 32. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 33. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 34. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 35. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 36. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 38. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 39. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 40. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 41. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 42. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 43. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 44. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 45. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 46. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 47. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 48. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 49. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 50. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 51. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 52. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Product
  • Table 53. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Modality
  • Table 54. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Viral
  • Table 55. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Non-Viral
  • Table 56. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Physical/mechanical Method
  • Table 57. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Chemical Method
  • Table 58. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by Application
  • Table 59. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million) - by End Users
  • Table 60. Recent Inorganic Growth Strategies in the Transfection Reagents and Equipment Market
  • Table 61. Recent Organic Growth Strategies in The Transfection Reagents and Equipment Market

List Of Figures

  • Figure 1. Europe Transfection Reagents and Equipment Market Segmentation, by Country
  • Figure 2. Impact Analysis of Drivers and Restraints
  • Figure 3. Europe Transfection Reagents and Equipment Market Revenue (US$ Million), 2022-2030
  • Figure 4. Europe Transfection Reagents and Equipment Market Share (%) - by Product (2022 and 2030)
  • Figure 5. Reagents: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 6. Equipment: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Europe Transfection Reagents and Equipment Market Share (%) - by Modality (2022 and 2030)
  • Figure 8. Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Retrovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Adenovirus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Adeno-Associated Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Herpes Virus: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Non-Viral: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Physical/Mechanical: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Electroporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Microinjection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Biolistic Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Laser Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Magnetofection: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Sonoporation: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Chemical Method: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Non-Liposomal Based/High Lipid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Hybrid: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Europe Transfection Reagents and Equipment Market Share (%) - by Application (2022 and 2030)
  • Figure 26. Biomedical Research: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Protein Production: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Therapeutic Delivery: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Transfection Reagents and Equipment Market Share (%) - by End Users (2022 and 2030)
  • Figure 30. Academic and Research Institutes: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 31. Pharmaceutical and Biotechnological Companies: Europe Transfection Reagents and Equipment Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. Europe: Transfection Reagents and Equipment Market- Revenue by Key Countries 2022 (US$ Million)
  • Figure 33. Europe: Transfection Reagents and Equipment Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 34. United Kingdom: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 35. Germany: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 36. France: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 37. Italy: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 38. Spain: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 39. Rest of Europe: Transfection Reagents and Equipment Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 40. Growth Strategies in The Transfection Reagents and Equipment Market, 2020-2023